Clinically beneficial continued treatment with gefitinib after asymptomatic progression of lung adenocarcinoma

We report a case showing the long-term clinical benefit of the continued use of gefitinib in a patient with asymptomatic progression of lung adenocarcinoma harboring an exon 19 deletion of the epidermal growth factor receptor gene. Although follow-up studies showed smoldering progression of metastat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Thorac Cancer
Main Authors: Choi, Hayoung, Chang, Jinsun, Shin, Hong-Joon, Park, Cheol-Kyu, Oh, In-Jae, Kim, Kyu-Sik, Kim, Young-Chul
Format: Artigo
Jezik:Inglês
Izdano: BlackWell Publishing Ltd 2015
Teme:
Case Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4448482/
https://ncbi.nlm.nih.gov/pubmed/26273363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12171
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki